Page last updated: 2024-08-21

fluorobenzenes and Bowel Diseases, Inflammatory

fluorobenzenes has been researched along with Bowel Diseases, Inflammatory in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Handa, O; Ichikawa, H; Isozaki, Y; Katada, K; Kokura, S; Naito, Y; Takagi, T; Tsuboi, H; Yoshida, N; Yoshikawa, T	1

Other Studies

1 other study(ies) available for fluorobenzenes and Bowel Diseases, Inflammatory

Article	Year
Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. International journal of molecular medicine, 2006, Volume: 17, Issue:6 Topics: Animals; Colitis; Colon; Cyclic N-Oxides; Dextran Sulfate; Female; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type III; Peroxidase; Pyrimidines; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha	2006

Article

Year

Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.

International journal of molecular medicine, 2006, Volume: 17, Issue:6

Topics: Animals; Colitis; Colon; Cyclic N-Oxides; Dextran Sulfate; Female; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type III; Peroxidase; Pyrimidines; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha

2006